Sweden· SE-20171030000040
Rifamycin Adalvo 200 mg Tablett med modifierad frisättning
A medicinal product containing rifamycin, registered in Sweden by Adalvo Limited.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Rifamycin
- Manufacturer
- Adalvo Limited
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20171030000040
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifamycin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainRIFAMICINA ADALVO 200 MG COMPRIMIDOS DE LIBERACION MODIFICADAAdalvo Competence Center S.R.L.
- PolandRifamycin AdalvoAdalvo Competence Center S.R.L.
- FranceOTOFA, solution auriculaire en gouttesBOUCHARA-RECORDATI
- ItalyDOTECINE*12 cpr 200 mg rilascio modificatoMALESCI SpA IST.FARMACOBIOL.
- BelgiumRifocine 500 IV 500 mgSanofi Belgium
- FinlandRelafalkAdalvo Competence Center S.R.L.
- GermanyGutiviaLunatus Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Rifocine I.V.
- Bulgaria · Relafalk
- Germany · Gutivia
- Finland · Relafalk
- France · Otofa, Rifamycine Chibret
- Greece · Relafalk
- Hungary · Relafalk
- Italy · Dotecine, Rifocin
- Luxembourg · Otofa, Rifocine I.V.
- Norway · Relafalk
- Poland · Relafalk
- Portugal · Imfalda, Rifocina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8d47cf5-842f-41d8-9702-6553b3b78361 GET /v1/drugs/e8d47cf5-842f-41d8-9702-6553b3b78361?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20171030000040",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20171030000040",
"product_doc_link": "https://docetp.mpa.se/LMF/Rifamycin%20Adalvo%20200%20mg%20modified-release%20tablet%20SmPC_09001bee84ae1089.pdf"
}See everything about rifamycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.